Business Context and Reporting Period
Company: Deckers Outdoor Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 1998
Business Overview: The Company designs, markets, and distributes outdoor footwear under the Teva, Simple, and Ugg brands. Operations are highly seasonal, with Teva sales peaking in Q1/Q2, Simple in Q3, and Ugg in Q4.
Key Financial Metrics
| Metric | Q1 1998 | Q1 1997 |
|---|---|---|
| Net Sales | $32,177,000 | $34,441,000 |
| Gross Profit | $13,537,000 | $14,950,000 |
| Gross Margin | 42.1% | 43.4% |
| Net Earnings | $1,753,000 | $1,990,000 |
| Earnings Per Share (Diluted) | $0.20 | $0.22 |
| Cash Flow from Operations | ($11,200,000) | ($1,418,000) |
| Cash and Equivalents (End of Period) | $2,129,000 | $1,481,000 |
| Total Debt (Current + Long-Term) | $21,064,000 | Filing text does not provide a clear total for Q1 1997 |
| Working Capital | $53,968,000 | Filing text does not provide a clear value for Q1 1997 |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 6.6% ($2.26 million) year-over-year. This was driven by a 28.2% drop in Simple brand sales and a 4.3% decline in Teva sales. The Teva decline is attributed to a successful Q4 1997 early delivery program that shifted approximately $5–$6 million of sales from Q1 1998 to Q4 1997.
- Margin Compression: Gross margin decreased to 42.1% from 43.4%, primarily due to higher volumes of Simple brand closeout sales, inventory write-downs, and lower-margin component sales.
- Operating Expenses: Selling, general, and administrative (SG&A) expenses decreased 5.8% to $10.15 million, largely due to reduced marketing and bad debt expenses, partially offset by higher R&D and legal costs.
- Cash Flow: Net cash used in operating activities increased significantly to $11.2 million (from $1.4 million used in 1997), driven by a $14.5 million increase in trade accounts receivable due to seasonality and extended payment terms for early deliveries.
- Debt Levels: Borrowings under the revolving credit facility increased to $20.3 million as of March 31, 1998, up from $2.0 million in notes payable at the end of 1997, to fund working capital needs.
Guidance, Outlook, and Risks
- Outlook: Management expects Teva sales to be relatively flat on a calendar basis in 1998 compared to 1997 due to the Q4 1997 shift. Simple sales are expected to remain lower than 1997 levels. Ugg sales are expected to increase. Operating expenses as a percentage of sales are expected to rise in 1998 due to increased spending on advertising, R&D, and international operations.
- Legal Contingencies: The Company is defending a 1995 lawsuit alleging trade secret infringement seeking $15 million in damages. Management believes the claims are without merit and does not anticipate a material adverse effect.
- Regulatory Risks: The European Commission has enacted 49.2% anti-dumping duties on footwear from China and Indonesia. Dutch Customs has indicated two popular Teva styles may be covered. If confirmed, this could impact future European sales or require sourcing changes.
- Year 2000 Issue: The Company is assessing internal systems and third-party readiness for the Year 2000 issue. While no material costs are currently anticipated, delays or failures by suppliers/customers could pose risks.
- Seasonality and Weather: Results are highly sensitive to weather conditions (e.g., cold springs hurting Teva, warm winters hurting Ugg) and consumer preferences.
Investor Verification Checklist
- Receivables Quality: Verify the collectability of the $37.4 million in trade receivables, which increased 62% from the prior quarter due to extended payment terms.
- Simple Brand Inventory: Assess the extent of inventory write-downs and closeout sales impacting the Simple brand margin.
- European Duty Exposure: Monitor the final determination by Dutch Customs regarding the applicability of anti-dumping duties to Teva styles.
- Credit Facility Covenants: Confirm the Company's ability to pay down debt to under $2.5 million for 30 consecutive days as required by the credit facility terms.
- Legal Proceedings: Track the status of the pending motion for summary judgment in the $15 million trade secret lawsuit.